Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial
Clinical trial NCT06126588 · RECRUITING
Trial details
- NCT number
- NCT06126588
- Sponsor
- Central Hospital, Nancy, France
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-29
- Primary completion
- 2026-03-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.